KC 516
Latest Information Update: 29 Nov 2006
Price :
$50 *
At a glance
- Originator Chugai Pharmaceutical
- Class
- Mechanism of Action Potassium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alopecia
Most Recent Events
- 11 May 2000 Preclinical development for Alopecia in Japan (Unknown route)